| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.64B | 19.30B | 18.49B | 17.02B | 17.22B | 18.16B |
| Gross Profit | 5.36B | 5.18B | 4.92B | 4.62B | 4.91B | 5.02B |
| EBITDA | 541.00M | 434.00M | 403.00M | 182.00M | 470.00M | 484.00M |
| Net Income | 241.00M | 81.00M | 284.00M | -326.00M | 198.00M | 232.00M |
Balance Sheet | ||||||
| Total Assets | 9.05B | 12.14B | 11.66B | 10.68B | 10.98B | 11.32B |
| Cash, Cash Equivalents and Short-Term Investments | 1.41B | 905.00M | 1.06B | 975.00M | 1.28B | 929.00M |
| Total Debt | 61.00M | 905.00M | 1.00B | 1.00B | 208.00M | 612.00M |
| Total Liabilities | 4.04B | 6.70B | 6.18B | 5.51B | 5.42B | 5.86B |
| Stockholders Equity | 5.00B | 5.43B | 5.48B | 5.16B | 5.56B | 5.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 140.00M | 107.00M | -917.00M | 930.00M | 788.00M |
| Operating Cash Flow | 0.00 | 241.00M | 130.00M | -805.00M | 1.04B | 829.00M |
| Investing Cash Flow | 0.00 | -153.00M | -43.00M | -205.00M | -168.00M | -73.00M |
| Financing Cash Flow | 0.00 | -241.00M | -2.00M | 707.00M | -520.00M | -920.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥18.54B | 13.52 | ― | 3.53% | 5.03% | -9.55% | |
75 Outperform | ¥9.59B | 12.83 | ― | 3.85% | 1.75% | 24.87% | |
68 Neutral | ¥14.63B | 10.17 | ― | 4.02% | 5.13% | -13.74% | |
66 Neutral | ¥21.85B | 23.11 | ― | ― | 30.15% | 31.28% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥2.92B | 3.81 | ― | 2.91% | 5.02% | 320.32% | |
59 Neutral | ¥12.60B | 37.44 | ― | 1.01% | 17.19% | -43.91% |